Table 4 |
||
|
Red Blood Cell Fatty Acid Analysis Data |
||
|
ADHD (n = 11) |
Control (n = 12) |
|
|
|
||
|
Total omega-3 Fatty Acids |
5.79 ± 1.39 † |
7.42 ± 1.64 |
|
Alpha-Linolenic Acid (18:3 n-3) |
0.16 ± 0.07 |
0.13 ± 0.09 |
|
Stearidonic Acid (18:4 n-3) |
0.07 ± 0.04 |
0.07 ± 0.04 |
|
20:3 n-3 |
0.02 ± 0.01 |
0.02 ± 0.01 |
|
Eicosatetraenoic Acid (20:4 n-3) |
0.05 ± 0.05 |
0.05 ± 0.04 |
|
Eicosapentaenoic Acid (20:5 n-3) |
0.51 ± 0.21 |
0.64 ± 0.24 |
|
Docosapentaenoic Acid (22:5 n-3) |
1.88 ± 0.71 |
2.03 ± 0.56 |
|
Docosahexaenoic Acid (22:6 n-3) |
3.12 ± 0.75 † |
4.39 ± 1.34 |
|
Total omega-6 Fatty Acids |
33.33 ± 1.83 |
32.51 ± 1.59 |
|
Linoleic Acid (18:2 n-6) |
13.26 ± 0.95 * |
12.02 ± 2.14 |
|
Gamma-Linolenic Acid (18:3 n-6) |
0.05 ± 0.03 |
0.06 ± 0.03 |
|
Eicosadienoic Acid (20:2 n-6) |
0.15 ± 0.07 |
0.14 ± 0.09 |
|
Dihomo-gamma-linolenic Acid (20:3 n-6) |
1.69 ± 0.20 * |
1.84 ± 0.51 |
|
Arachidonic Acid (20:4 n-6) |
14.51 ± 1.67 |
14.73 ± 1.48 |
|
Docosadienoic Acid (22:2 n-6) |
0.05 ± 0.03 |
0.04 ± 0.06 |
|
Adrenic Acid (22:4 n-6) |
3.61 ± 1.33 |
3.63 ± 0.72 |
|
Docosapentanoic Acid (22:5 n-6) |
0.03 ± 0.03 |
0.07 ± 0.01 |
|
n-3: n-6 Ratio |
0.17 ± 0.04 † |
0.23 ± 0.06 |
|
n-6: n-3 Ratio |
5.86 ± 2.04 * |
4.64 ± 1.27 |
|
AA/EPA |
31.61 ± 8.91 |
26.04 ± 10.27 |
|
Total Saturated Fatty Acids |
39.38 ± 1.79 |
39.26 ± 1.16 |
|
Total Monounsaturated Fatty Acids |
21.51 ± 1.15 |
20.81 ± 1.15 |
|
Total Polyunsaturated Fatty Acids |
39.11 ± 2.48 |
39.93 ± 1.76 |
|
|
||
|
Values are means +/- standard deviation and given as a mol % of total fatty acids. † Significant difference between groups (p < 0.02), * Difference between groups (p = 0.095) |
||
|
Colter et al. Nutrition Journal 2008 7:8 doi:10.1186/1475-2891-7-8 |
||